1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Pharmacy Automation Systems Market
4. Market Overview
4.1. Introduction
4.1.1. Product Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
5. Key Insights
5.1. Technological Advancement
5.2. Key Industry Events
5.3. COVID-19 Pandemic Impact on Industry
6. Global Pharmacy Automation Systems Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product Type, 2017–2031
6.3.1. Medication Dispensing Systems
6.3.2. Packaging and Labelling Systems
6.3.3. Table-top Counters
6.3.4. Storage and Retrieval Systems
6.3.5. Others (Medication Compounding Systems, etc.)
6.4. Market Attractiveness Analysis, by Product Type
7. Global Pharmacy Automation Systems Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by End-user, 2017–2031
7.3.1. Retail Pharmacies
7.3.2. Inpatient Pharmacies
7.3.3. Outpatient Pharmacies
7.3.4. Others (PBMOs, Mail Order Pharmacies, etc.)
7.4. Market Attractiveness Analysis, by End-user
8. Global Pharmacy Automation Systems Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis, by Region
9. North America Pharmacy Automation Systems Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Product Type, 2017–2031
9.2.1. Medication Dispensing Systems
9.2.2. Packaging and Labelling Systems
9.2.3. Table-top Counters
9.2.4. Storage and Retrieval Systems
9.2.5. Others (Medication Compounding Systems, etc.)
9.3. Market Value Forecast, by End-user, 2017–2031
9.3.1. Retail Pharmacies
9.3.2. Inpatient Pharmacies
9.3.3. Outpatient Pharmacies
9.3.4. Others (PBMOs, Mail Order Pharmacies, etc.)
9.4. Market Value Forecast, by Country, 2017–2031
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Product Type
9.5.2. By End-user
9.5.3. By Country
10. Europe Pharmacy Automation Systems Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product Type, 2017–2031
10.2.1. Medication Dispensing Systems
10.2.2. Packaging and Labelling Systems
10.2.3. Table-top Counters
10.2.4. Storage and Retrieval Systems
10.2.5. Others (Medication Compounding Systems, etc.)
10.3. Market Value Forecast, by End-user, 2017–2031
10.3.1. Retail Pharmacies
10.3.2. Inpatient Pharmacies
10.3.3. Outpatient Pharmacies
10.3.4. Others (PBMOs, Mail Order Pharmacies, etc.)
10.4. Market Value Forecast, by Country/Sub-region, 2017–2031
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Italy
10.4.5. Spain
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Product Type
10.5.2. By End-user
10.5.3. By Country/Sub-region
11. Asia Pacific Pharmacy Automation Systems Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2017–2031
11.2.1. Medication Dispensing Systems
11.2.2. Packaging and Labelling Systems
11.2.3. Table-top Counters
11.2.4. Storage and Retrieval Systems
11.2.5. Others (Medication Compounding Systems, etc.)
11.3. Market Value Forecast, by End-user, 2017–2031
11.3.1. Retail Pharmacies
11.3.2. Inpatient Pharmacies
11.3.3. Outpatient Pharmacies
11.3.4. Others (PBMOs, Mail Order Pharmacies, etc.)
11.4. Market Value Forecast, by Country/Sub-region, 2017–2031
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealend
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Product Type
11.5.2. By End-user
11.5.3. By Country/Sub-region
12. Latin America Pharmacy Automation Systems Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2017–2031
12.2.1. Medication Dispensing Systems
12.2.2. Packaging and Labelling Systems
12.2.3. Table-top Counters
12.2.4. Storage and Retrieval Systems
12.2.5. Others (Medication Compounding Systems, etc.)
12.3. Market Value Forecast, by End-user, 2017–2031
12.3.1. Retail Pharmacies
12.3.2. Inpatient Pharmacies
12.3.3. Outpatient Pharmacies
12.3.4. Others (PBMOs, Mail Order Pharmacies, etc.)
12.4. Market Value Forecast, by Country/Sub-region, 2017–2031
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
12.5.1. By Product Type
12.5.2. By End-user
12.5.3. By Country/Sub-region
13. Middle East & Africa Pharmacy Automation Systems Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2017–2031
13.2.1. Medication Dispensing Systems
13.2.2. Packaging and Labelling Systems
13.2.3. Table-top Counters
13.2.4. Storage and Retrieval Systems
13.2.5. Others (Medication Compounding Systems, etc.)
13.3. Market Value Forecast, by End-user, 2017–2031
13.3.1. Retail Pharmacies
13.3.2. Inpatient Pharmacies
13.3.3. Outpatient Pharmacies
13.3.4. Others (PBMOs, Mail Order Pharmacies, etc.)
13.4. Market Value Forecast, by Country/Sub-region, 2017–2031
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Market Attractiveness Analysis
13.5.1. By Product Type
13.5.2. By End-user
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player – Competition Matrix (By Tier and Size of Companies)
14.2. Market Share Analysis, by Company (2022)
14.3. Company Profiles
14.3.1. BD Rowa
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Product Portfolio
14.3.1.3. Financial Overview
14.3.1.4. SWOT Analysis
14.3.1.5. Strategic Overview
14.3.2. Omnicell, Inc.
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Product Portfolio
14.3.2.3. Financial Overview
14.3.2.4. SWOT Analysis
14.3.2.5. Strategic Overview
14.3.3. ScriptPro
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Product Portfolio
14.3.3.3. Financial Overview
14.3.3.4. SWOT Analysis
14.3.3.5. Strategic Overview
14.3.4. KirbyLester (Capsa Healthcare) Automation
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Product Portfolio
14.3.4.3. Financial Overview
14.3.4.4. SWOT Analysis
14.3.4.5. Strategic Overview
14.3.5. Swisslog Healthcare (KUKA)
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Product Portfolio
14.3.5.3. Financial Overview
14.3.5.4. SWOT Analysis
14.3.5.5. Strategic Overview
14.3.6. ARxIUM
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Product Portfolio
14.3.6.3. Financial Overview
14.3.6.4. SWOT Analysis
14.3.6.5. Strategic Overview
14.3.7. Parata Systems, LLC
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2. Product Portfolio
14.3.7.3. Financial Overview
14.3.7.4. SWOT Analysis
14.3.7.5. Strategic Overview
14.3.8. McKesson Corporation
14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2. Product Portfolio
14.3.8.3. Financial Overview
14.3.8.4. SWOT Analysis
14.3.8.5. Strategic Overview
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
